1-40835347-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004700.4(KCNQ4):​c.1745+249T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.454 in 152,196 control chromosomes in the GnomAD database, including 17,299 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 17299 hom., cov: 33)

Consequence

KCNQ4
NM_004700.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.16

Publications

3 publications found
Variant links:
Genes affected
KCNQ4 (HGNC:6298): (potassium voltage-gated channel subfamily Q member 4) The protein encoded by this gene forms a potassium channel that is thought to play a critical role in the regulation of neuronal excitability, particularly in sensory cells of the cochlea. The current generated by this channel is inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. The encoded protein can form a homomultimeric potassium channel or possibly a heteromultimeric channel in association with the protein encoded by the KCNQ3 gene. Defects in this gene are a cause of nonsyndromic sensorineural deafness type 2 (DFNA2), an autosomal dominant form of progressive hearing loss. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
KCNQ4 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 2A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 1-40835347-T-C is Benign according to our data. Variant chr1-40835347-T-C is described in ClinVar as Benign. ClinVar VariationId is 1242460.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.759 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004700.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ4
NM_004700.4
MANE Select
c.1745+249T>C
intron
N/ANP_004691.2
KCNQ4
NM_172163.3
c.1583+249T>C
intron
N/ANP_751895.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ4
ENST00000347132.10
TSL:1 MANE Select
c.1745+249T>C
intron
N/AENSP00000262916.6
KCNQ4
ENST00000967337.1
c.1685+249T>C
intron
N/AENSP00000637396.1
KCNQ4
ENST00000967338.1
c.1628+249T>C
intron
N/AENSP00000637397.1

Frequencies

GnomAD3 genomes
AF:
0.454
AC:
69020
AN:
152078
Hom.:
17299
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.244
Gnomad AMI
AF:
0.530
Gnomad AMR
AF:
0.427
Gnomad ASJ
AF:
0.530
Gnomad EAS
AF:
0.778
Gnomad SAS
AF:
0.559
Gnomad FIN
AF:
0.527
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.538
Gnomad OTH
AF:
0.471
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.454
AC:
69026
AN:
152196
Hom.:
17299
Cov.:
33
AF XY:
0.455
AC XY:
33877
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.243
AC:
10104
AN:
41530
American (AMR)
AF:
0.427
AC:
6531
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.530
AC:
1839
AN:
3468
East Asian (EAS)
AF:
0.779
AC:
4030
AN:
5174
South Asian (SAS)
AF:
0.557
AC:
2685
AN:
4818
European-Finnish (FIN)
AF:
0.527
AC:
5592
AN:
10608
Middle Eastern (MID)
AF:
0.558
AC:
164
AN:
294
European-Non Finnish (NFE)
AF:
0.538
AC:
36593
AN:
68000
Other (OTH)
AF:
0.478
AC:
1007
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1873
3745
5618
7490
9363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
636
1272
1908
2544
3180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.486
Hom.:
3122
Bravo
AF:
0.436
Asia WGS
AF:
0.645
AC:
2241
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.011
DANN
Benign
0.48
PhyloP100
-3.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs729589; hg19: chr1-41301019; API